Detecting Depression and Anxiety Among Adolescents in South Africa: Validity of the isiXhosa Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7.Show others and affiliations
2023 (English)In: Journal of Adolescent Health, ISSN 1054-139X, E-ISSN 1879-1972, Vol. 72, no S1, p. S52-S60Article in journal (Refereed) Published
Abstract [en]
PURPOSE: Screening tools such as the Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder-7 (GAD-7) could potentially be used in resource-limited settings to identify adolescents who need mental health support. We examined the criterion validity of the isiXhosa versions of the PHQ-9 and GAD-7 in detecting depression and anxiety among adolescents (10-19 years) in South Africa.
METHODS: Adolescents were recruited from the general population and from nongovernmental organizations working with adolescents in need of mental health support. The PHQ-9 and GAD-7 were culturally adapted and translated into isiXhosa and administered to 302 adolescents (56.9% female). The Kiddie Schedule for Affective Disorders and Schizophrenia was administered by trained clinicians as the gold standard diagnostic measure for depression and anxiety.
RESULTS: For the PHQ-9, the area under the curve was 0.88 for the full sample of adolescents (10-19 years old). A score of ≥10 had 91% sensitivity and 76% specificity for detecting adolescents with depression. For the GAD-7, the area under the curve was 0.78, and cutoff scores with an optimal sensitivity-specificity balance were low (≥6). A score of ≥6 had 67% sensitivity and 75% specificity for detecting adolescents with anxiety.
DISCUSSION: The culturally adapted isiXhosa version of the PHQ-9 can be used as a valid measure for depression in adolescents. Further research on the GAD-7 for use with adolescents is recommended.
Place, publisher, year, edition, pages
Elsevier, 2023. Vol. 72, no S1, p. S52-S60
Keywords [en]
Adolescents, Anxiety, Depression, Diagnostic assessment, GAD-7, Low- and middle-income countries, Mental health, PHQ-9, Screening, Validity
National Category
Psychiatry
Identifiers
URN: urn:nbn:se:rkh:diva-4388DOI: 10.1016/j.jadohealth.2022.09.013PubMedID: 36274021OAI: oai:DiVA.org:rkh-4388DiVA, id: diva2:1706269
Funder
Bill and Melinda Gates Foundation, INV-0013952022-10-252022-10-252023-01-03Bibliographically approved